
NYSE:MET
This summary was created by AI, based on 1 opinions in the last 12 months.
MetLife, represented by the symbol MET-N, has recently achieved a significant milestone by reaching a 52-week high, indicative of a robust performance in the market. Experts highlight its solid, conservative approach, which is aligned with defensive investment strategies. This positions MetLife favorably, as it focuses on investments that are deemed stable and secure, appealing particularly to risk-averse investors. The company's commitment to prudent asset management and reliable returns has garnered positive attention, suggesting a well-regarded reputation within the financial sector. Overall, MetLife appears to be a company that is making significant strides while adhering to fundamental principles of risk management and investment that many experts find admirable.
Metlife is a American stock, trading under the symbol MET (previously MET-N on Stockchase) on the New York Stock Exchange (MET). It is usually referred to as NYSE:MET or MET
In the last year, 1 stock analyst issued a Buy, Sell, or Hold rating on MET (previously MET-N on Stockchase). 1 analyst recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is BUY. Read the latest stock experts' ratings for Metlife.
Metlife was recommended as a Top Pick by Jim Cramer - Mad Money on 2026-06-10. Read the latest stock experts ratings for Metlife.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Metlife.
Metlife is followed by 36 investors on Stockchase and is a trending stock that is worth watching.
On 2026-09-04, Metlife (MET) stock closed at a price of $97.62.
Just made a 52-week high. Solid, conservative and defensive, invested in the right things.